Contract research organization ICON is set to acquire rival PRA Health Sciences in a $12 billion deal that will vault the combined company into second place among clinical trial services providers.

PRA Group (PRAA) was trading lower after Citizens downgraded the stock, citing the business appears to be several years away from delivering reliably consistent profitability.

PRA Group allowed inefficiencies and operational issues in collections, purchasing, and overall operations to accumulate, driving terrible results in 2023 and a change in management. New management ...

Researchers have identified a genetic mutation causing progressive retinal atrophy (PRA) in the Phalene and Papillon dog breeds. PRA is one of the most common causes of blindness in dogs and in human.

Contract research organization PRA Health has launched a new mobile app aimed at tracking patients’ physical and psychological symptoms from COVID-19. The new app, the CRO explains, allows employers, ...

PRA Group’s consensus analyst price target has recently shifted, moving from $23.33 to $22.67. This adjustment reflects a mix of confidence and caution among analysts, who are weighing improved ...

The consolidation brings together two organizations with a history of robust growth and performance ready to build on this strength using the outstanding talent of both companies to deliver enhanced ...

RALEIGH, N.C. – PRA, a leading clinical research organization, today announced it has acquired privately held ClinStar, LLC, a clinical research organization managing Phase I-IV clinical research ...

RALEIGH, N.C.--(BUSINESS WIRE)--PRA International (“PRA”), a leading clinical research organization, today announced the completion of its merger with ReSearch Pharmaceutical Services (“RPS”) and the ...